Published research
Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
Natural killer (NK) cells have an intrinsic ability to detect and eliminate leukaemic cells. Cellular therapies using cytokine-activated NK cells have emerged as promising treatments for patients with advanced leukaemia. However, not all patients respond to current NK cell therapies, and thus improvements in efficacy are required.
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells
Recent evidence suggests that burn patients are at increased risk of hospital admission for infection, mental health conditions, cardiovascular disease and cancer for many years after discharge for the burn injury itself.
Education and Qualifications
- PhD (2008): University of Western Australia
- BSc(Biomedical Sciences)(Hons)(2003): University of Western Australia
Active Collaborations
- Dr Jason Waithman, UWA
- Prof. Ryan Lister and Dr Christian Pflueger, Harry Perkins Institute for Medical Research
- Dr Benedict Carnley, Cell and Tissue Therapies WA
- Dr Paul Beavis, Peter MacCallum Cancer Centre